AI Terminal
Photocure ASA
Report Publication Announcement • Apr 30, 2025
3714_rns_2025-04-30_8f0fab0d-0222-4a7d-96cc-abada3ec86f3.pdf
Report Publication Announcement
Open in ViewerOpens in native device viewer
Photocure ASA: Invitation to presentation of first quarter 2025 financial results
Oslo, Norway, 30 April 2025: Photocure ASA (Photocure, PHO: OSE) will announce the first quarter 2025 financial results on Thursday 8 May 2025 at 07:00 CEST and will present a live webcast at 14:00 CEST the same day.
The quarterly report and presentation will be published at 07:00 CEST and will be publicly available at www.photocure.com.
The investor presentation will be streamed live and be hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45 CEST.
The streaming event is available through http://channel.royalcast.com/landingpage/hegnarmedia/20250508\_10/
For further information, please contact:
Photocure
Erik Dahl CFO Tel: +47 45055000 Email: [email protected]
Jonas Fougner Interim IRO Tel: +47 94805851 Email: [email protected]
Media and IR enquiries: Geir Bjørlo Corporate Communications (Norway) Tel: +47 91540000 Email: [email protected]
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo,
Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com and www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.